Human Metabolome Technologies Inc. (HMT) is a global leader of metabolome analysis service provider. From 2003, we have worked with over 400 clients per year from Asia to the Americas and Europe, and contributed to over 200 publications in high impact journals including Science and Nature. Our unique Capillary Electrophoresis Mass Spectrometry (CE-MS) technology enables high sensitive and quantitative measurement of over thousands small compounds, especially involved in essential metabolic pathways for disease and biomass production. Together qualified analysis based on GLP graded SOP, our experienced research coordinators support client’s project goal with consultation for study design and data analysis .
Funded at 2003 in Japan, HMT has operated under the mission of providing unique and high quality metabolomics solution to all researchers in the world. The founders, Drs. Masaru Tomita and Tomoyoshi Soga, has developed multiomics platform in Keio University and has established CE-MS based metabolic profiling system. Based on this core technology, HMT has developed commercial analysis service packages including global profiling, target assay and isotope labeling. HMT America has opened at 2012 to develop US and EU market.